IRIDEX Corporation (IRIX) NASDAQ
1.05
+0(+0.48%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.05
+0(+0.48%)
Currency In USD
| Previous Close | 1.05 |
| Open | 1.05 |
| Day High | 1.06 |
| Day Low | 1.03 |
| 52-Week High | 1.65 |
| 52-Week Low | 0.87 |
| Volume | 11,572.99 |
| Average Volume | 267,309 |
| Market Cap | 18.17M |
| PE | -4.04 |
| EPS | -0.26 |
| Moving Average 50 Days | 1.25 |
| Moving Average 200 Days | 1.2 |
| Change | 0 |
Iridex Announces Plans to Relocate Headquarters
GlobeNewswire Inc.
Feb 02, 2026 12:00 PM GMT
Move expected to generate significant cost savingsMOUNTAIN VIEW, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and p
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
GlobeNewswire Inc.
Jan 12, 2026 12:00 PM GMT
Demonstrating continued revenue growth, operational efficiencies and positive cash flowMOUNTAIN VIEW, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based med
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
GlobeNewswire Inc.
Dec 11, 2025 12:00 PM GMT
MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retin